Synergistic IL-1 pathway genetic variants amplify susceptibility and inflammatory severity in COVID-19
IL-1 pathway genetic variants are associated with COVID-19 susceptibility and inflammatory biomarker profiles and integration of host genetic markers with clinical factors may improve risk stratification and support precision immunomodulatory strategies.